References
- 1. Hoffmann S, Tittgemeyer M, von Cramon DY.(2007) Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007; 20(3): 275-80.10.1097/WCO.0b013e32810c8e87
- 2. Amato MP, Zipoli V, Portaccio E.(2006) Multiple sclerosis-related cognitive changes: a review of crosssectional and longitudinal studies. J Neurol Sci 2006; 245(1-2): 41-6.
- 3. Barker-Collo SL.(2005) Within session practice effects on the PASAT and clients with multiple sclerosis. Arch Neuropsychol Clin. 2005; 20(2): 145-52.
- 4. Ivica N, Titlic M, Pavelin S. (2013) P300 wave changes in patients with multiple sclerosis. Acta Med Inform. 2013; 21(3): 205-7.10.5455/aim.2013.21.205-207
- 5. Piras MR, Sognano I, Cani ED at all. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological and neurophysiological findings. J Neurol, Neurosurg, Psychiatry 2003;74:878-885.10.1136/jnnp.74.7.878
- 6. Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Bramham J, O’Brien M, Reilly RB, Hutchinson M, Tubridy N. A high-density ERP study reveals latency, amplitude, and topographical differences in multiple sclerosis patients versus controls. Clin Neurophysiol 2010;121(9):1420-6.
- 7. Kiiski H, Reilly RB, LonerganR at all.(2011) Change in PASAT correlates with in P3 ERP amplitude over a 12-month period in multiple sclerosis patients. Journal of the Neurological Science 2011;305(1):42-52.
- 8. Sailer M, Heinze HJ, Tendolkar I, Decker U, KreyeO, v Rolbicki U, Münte TF (2001). Influence of cerebral lesion volume and lesion distribution on eventrelated brain potentials in multiple sclerosis. J Neurol 2001;248(12):1049-55.
- 9. Mathias Sundgren, Vadim V, Nikulin, Liselotte Maurex, ÅkeWahlin, Fredrik Piehl, Tom Brismar. (2015) P300 amplitude and response speed relate to preserved cognitive function in relapsing–remitting multiple sclerosis. Clinical Neurophysiology 2015;126(4):689-697.
- 10. Filippi, M, Rocca, MA, Benedict RHB, DeLuca J, Geurts JG, Rombouts, SARB, Ron, M, andComi G. (2010) The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010;75(23): 2121–2128.
- 11. Mainero C, Caramia F, Pozzilli C, Pisani A, Pestalozza I, Borriello G et al. (2004) fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage 2004;21(3):858-67.10.1016/j.neuroimage.2003.10.004
- 12. Roy S, Benedict RH , Drake AS, Weinstock-Guttman B.(2016) Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis. CNS Drug 2016; 30(3): 209-225.
- 13. Filipovic S, Drulovic J, Stojisavljevic N, Levic Z.(1997) The effects of high-dose intravenous methylprednisolone on event-related potentials in patients with multiple sclerosis. J of Neurological Science 1997;152:147-153.
- 14. Baykara E, Ruf CA, Fioravanti C, Käthner I, Simon N, Kleih SC, Kübler A, Halder.(2016) Effects of training and motivation on auditory P300 brain-computer interface performance. Clin Neurophysiol 2016; 127(1):379-87.